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Abstract: The overarching principle of three-dimensional (3D) bioprinting is the placing of cells or cell clusters in the 3D 
space to generate a cohesive tissue microarchitecture that comes close to in vivo characteristics. To achieve this goal, several 
technical solutions are available, generating considerable combinatorial bandwidth: (i) Support structures are generated first, 
and cells are seeded subsequently; (ii) alternatively, cells are delivered in a printing medium, so-called “bioink,” that contains 
them during the printing process and ensures shape fidelity of the generated structure; and (iii) a “scaffold-free” version of 
bioprinting, where only cells are used and the extracellular matrix is produced by the cells themselves, also recently entered 
a phase of accelerated development and successful applications. However, the scaffold-free approaches may still benefit from 
secondary incorporation of scaffolding materials, thus expanding their versatility. Reversibly, the bioink-based bioprinting 
could also be improved by adopting some of the principles and practices of scaffold-free biofabrication. Collectively, we 
anticipate that combinations of these complementary methods in a “hybrid” approach, rather than their development in 
separate technological niches, will largely increase their efficiency and applicability in tissue engineering.
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1. Biofabrication of Tissue Analogs - The 
Main Approaches
Biofabrication, the three-dimensional (3D) assembly of 
living cells in structured systems [1], has evolved in the past 
decades as the biological facet of additive manufacturing [2]. 
Technically, biofabrication can be roughly divided into 
“bioprinting,” a technology akin to the classical use of 
ink and paper [3], and “tissue assembly”  [4], where other 
techniques such as “tissue strands” [5], lamination of 
“cell sheets” [6] or cell spheroid piercing-and-stringing [7], 
have recently evolved. The purpose is to assemble cells 
into a living, functional system that serves for in vitro 
drug development and substance testing, or as an in vivo 
implantable tissue [1]. However, the boundaries between 
approaches are blurring, because they will be increasingly 
shared to create synergies with an eclectic mix of techniques 
for reaching specific goals. In future, the combined use 
of the main approaches in biofabrication will likely lead 
to more “hybrid” systems and subsequent expectations 
on appropriate instrumentation [8]. For this reason, in our 
overview, we will discuss the strengths and weaknesses of 
these approaches, according to their main features.
Moroni et al., Groll et al. [1,4] and Moldovan [9] have 
noticed some confusion regarding the terminology in this 
field. Therefore, here we need to specify again what - in our 
opinion - 3D Bioprinting is not: namely, it is not the mere 
additive manufacturing (a.k.a. 3D printing) of implantable 
materials which, by all intents and purposes, would be 
“biomaterials” [10]. The implantation of such a material 
aims either at total immunological inertia (sometimes 
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also misnamed in this context as “biocompatibility),” or 
alternatively seeks histo-integration, and therefore the 
implant’s colonization by cells that migrate onto and into its 
structure [11]. As an example, the osteoinductive structures 
made of various materials can be considered [12]. This 
approach is common in regenerative medicine, constituting 
a form of “in vivo tissue engineering” with the host tissue 
acting as a bioreactor  [13]. In this case, a tissue-repairing 
activity requires merely shape and mechanical function 
of interest; therefore, the used materials are polymeric or 
natural/decellularized fibrillar matrices. Hydrogels, another 
major medium for tissue engineering, are also occasionally 
injected directly in the recipients to elicit a repairing 
response either by themselves or often as cell carriers [14].
Many bona fide 3D biofabrication tasks primarily target 
the in vitro applications, and either include the spatial 
arrangement of living cells during the printing process or 
make them adhere in a directed manner on specifically 
preprinted structures. As a future development, pre-
existing structures of living host tissues might be 
considered as the equivalent of preprinted structures and 
therefore might invite direct in vivo printing approaches 
onto wound grounds [15].
Whatever the approach, biofabrication is done with 
the understanding that besides a variety of cells, animal 
tissues contain various proportions of extracellular matrix 
(ECM) in the form of fibrils, fibrillary networks, sheaths, 
and hydrogels, as well as a fluid phase representing a 
complex mixture of molecules with metabolic or signaling 
functions. Correspondingly, a re-creation of tissue analogs 
largely recapitulates this blueprint (Figure 1).
1.1 Bioprinting
1.1.1 The Print and Populate Approach
In this approach, support structures are printed first, and 
cells are positioned subsequently on them in a targeted 
way. Often a layer-by-layer deployment method is 
pursued, such that lines of the hydrogel are printed 
first, and then covered by jetted cells [16]. The system 
works by printing bioinks in contact mode followed by 
polymerization (e.g., by ultraviolet light) of the printed 
lines, and subsequent jetting of cells onto printed lines 
in nanodroplets. One such cycle can be repeated several 
times resulting in a layered structure [16]. Since hydrogels 
are materials with an absorptive surface, they could take 
up the excess fluid from the jetted droplets.
The print and populate method also works with hard 
materials, such as polycaprolactone. In tissue engineering, 
another version of this method is the colonization with 
cells of fibrillar and/or porous scaffolds prepared by 
electrospinning. This is usually performed after the shape 
of the scaffold is pre-determined, such as layer and tube [17]. 
However, for cell placement, simple cell sedimentation 
usually does not suffice, because the superficial pores 
are quickly clogged, preventing their further penetration 
in the scaffold. To force them inside of the structure, the 
cells may need to be exposed to negative pressure [18], to 
gravitational (centrifugation) [19] or magnetic [20] forces.
1.1.2 Direct Cells Printing - the Role of Bioinks
A typical commercial bioprinter offers the extrusion 
mode, by which a viscous medium is continuously 
expelled from ready-to-use cartridges through printing 
needles or nozzles. The extrusion can be achieved through 
microvalves propelling the extrudate downward, a plunger 
system, or in the case of very viscous materials, a screw 
pump [21]. The cells are delivered in a printing medium, the 
so-called “bioink,” that contains them during the printing 
process, ensures shape fidelity of the printed structure, 
and protects cells against shear forces [22]. Alternatively, 
the bioinks might be deployed by inkjet methods [23], one 
of which is laser-assisted droplet generation [24,25].
Technically, the bioinks represent scaffolds, which is 
particularly obvious after chemical, photo or enzymatic 
crosslinking [26]. Therefore, to avoid confusion, occasional 
claims (e.g., [27]) that bioink-based printing starting 
with more fluid solutions, or because these are further 
Figure 1. Graphic overview of the biofabrication methods.
 Moldovan NI, et al.
 International Journal of Bioprinting (2019)–Volume 5, Issue 1 3
combined with fibrillar meshes, would be “scaffold-free,” 
should not be entertained.
1.1.3 Scaffold-in-scaffold: Integrated or Composite 3D 
Bioprinting
When the hydrogels alone do not attain enough strength 
by polymerization, another option is to print harder or 
stiffer scaffolds as cage-like system first and then to fill 
them with cell-laden bioinks on hydrogel-basis [28]. For 
this, the terms of “composite” [29], “integrated” [30] or even 
“hybrid” [31] bioprinting have been coined.
1.1.4 Advantages and Limitations of Hydrogels-based 
Bioprinting
Although only a few decades old, the concept of 
bioprinting and the instruments operated on this principle 
inspired from additive manufacturing have progressed 
impressively and already generated convincing proofs of 
concept. Responding to a large societal interest, a market 
emerged for commercialization of a variety of bioprinting 
materials and instruments. However, with bioink-based 
bioprinting, it is not trivial to satisfy simultaneously the 
requirement of both printability and biocompatibility [22]. 
Essentially, bioinks are soft biomaterials, which need to 
permit extrusion or jetting, yet are required to maintain a 
printed shape. This is achieved by employing thixotropic 
gels that show shear-thinning during an extrusion process 
and regain larger stiffness immediately after deposition 
or a by the post-printing chemical crosslinking process. 
These bioink modifications have consequences for 
cellular viability and proliferative and migratory behavior. 
Cell damage and post-printing dysfunctionality may 
occur for a variety of reasons, such as high shear stress, 
lack of growth factors or suitable ECM, or limitation of 
intercellular communication [9]. Despite promising results 
in this direction, an ideal bioink is yet to be found. Taking 
into consideration that there are so many different cell 
types in the body, all with their refined needs regarding 
the microenvironment, it appears that a variety of suitable 
bioinks still have to be developed to address the needs of 
different cell types. In addition, the constructs obtained 
by the current bioprinting techniques display a simplistic 
cellular architecture. For example, although pre-vascular 
tubes could be embedded in the structural bioink as 
“sacrificial” hydrogels [28], their patterns lack the fractal 
organization of natural microvascular networks.
In summary, this approach relies on hydrogels as 
primary shape generators and cell carriers. While it 
remains promising for large, cell-homogenous, matrix-
rich tissues, representing mostly the skeletal-muscular 
system, it is still struggling to solve its hard to conciliate 
requirements, related to the hydrogels printability on 
one side, and cellular needs on the other. More work 
will need to be invested into self-organizing systems, 
where main (yet small) blood vessels can be printed into 
tissue constructs, to further allow sprouting from and to 
capillary systems. Cleary, the fourth dimension comes 
into play, namely the time-component of maturation.
2. Tissue Assembly
In this section, we describe 3D tissue engineering methods 
that do not make overt use of the ink and paper analogy. 
In most cases, the methods of this type could be called 
“scaffold-free,” indicating a version of biofabrication where 
only cells are used, and the needed matrix is produced by 
the cells themselves. With regard to the configuration of 
the cells in the initial assembly step, this approach comes 
in two variants: A planar and a spherical mode.
2.1 Planar Biofabrication
This mode works with cell sheets that have a preferred two-
dimensional distribution. In essence, this biofabrication 
method is a lamination approach and hinges on the 
adhesion of cells to a substrate and the ECM produced 
by them. Thanks to a thermosensitive polymer (NiPAAM 
and pNIPAAM) as a support structure, a reduction of 
temperature below standard cultivation at 37°C will lead 
to a repulsion of the cell layer from the polymer, leading 
to the detachment of the cell culture as a contiguous cell 
sheet [32]. Several cell sheets can be stacked, thus resulting 
in a multilayered tissue [33]. The approach, originally 
proposed by Michael Sefton for drug delivery purposes, 
later developed as a tissue engineering mode [34] and was 
driven forward by Owaki et al. [35].
2.2 The Spheroidal Mode of Cell Assembling
2.2.1 Make and Cast
The 3D nature of tissues’ architecture is well captured 
by employing cell spheroids. Frequently referred to also 
as “microtissues” [36] they are increasingly preferred to 
isolated cells to improve the efficacy of cell therapy [37], 
or particularly as tumor models (oncospheres) [38]. 
When these spheroids are grown from stem cells, they 
are called “organoids” (or “embryoid bodies” in the 
case of embryonic or induced pluripotent stem cells), 
representing a promising new development in tissue 
engineering [39]. Alternatively, cell aggregates can be also 
prepared as cell cords, for example, for further processing 
into spheroids [40].
A completely different bioprinting approach is based 
on the notion that the cell clusters forming spheroids 
merge when brought into contact with each other [41]. The 
fusion of spheroids is based on the same principles that 
govern their formation in the first place: Minimization of 
a system’s potential energy, generated by the adhesive 
interactions between cells, through intercellular adhesion 
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molecules, mainly the cadherins and connexins [42]. The 
cell cytoskeleton [43] and metabolism may also have 
indirect roles but probably are less important than direct 
cell-cell attachment. A good argument that spheroid fusion 
is relatively well understood is the ability to simulate it 
by computer modeling on several platforms, for example, 
CompuCell3D [44], initially developed around this type of 
applications [45]. We recently expanded a similar model 
to capture the role of oxygen during spheroid fusion in 
larger structures [46].
Spheroid generation is best achieved by placing the cells 
on non-binding surfaces either in large flat or small, round 
wells [47]. Cells sedimenting on a surface that offers no 
anchorage will adhere to other cells thus forming spherical 
clusters, a tendency that can be promoted by small inverse 
pyramidal depressions [48]. Depending on geometry and 
coating, the latter allows for homodisperse spheroid sizes, 
while larger non-binding wells might give rise to numerous 
differently sized spheroids. The spheroids so formed then 
have to be repositioned to induce them to fuse into 3D 
structures. To this end, the spheroids can be placed in 
molds where they form 3D structures by fusing [41]. Tissue 
models of cartilage [49], or cardiac patches prepared from 
spheroids fused by flotation on culture medium [50], as well 
as vascular rings [51] and tumor models [52] assembled by 
magnetic force, have been described. As a variant, thicker 
honeycomb-shaped cell toroids prepared in molds, then 
stacked in register, and fused in larger constructs were 
proposed for improved distribution of nutrients, even in 
the absence of a bona fide vascularization [53].
2.2.2 Pick and Place
Alternatively, spheroids can be individually manipulated 
by dedicated instruments (such as the “Fabion” 
bioprinter [54]), and placed in a pattern on support where 
they fuse and form hollow or mixed massive structures. 
Interestingly, the targeted placement of spheroids on 
support (which some authors address as “biopaper” [55-57]) 
refers back to the printing analogy.
To facilitate the formation of 3D constructs from 
spheroids, a method was needed to keep them in contact 
long enough to effect fusion, and at the same time to allow 
the cells to produce their own ECM [58]. The companies 
Organovo [59] and 3D Bioprinting Solutions [54] are 
performing this step on their bioprinters using “fugitive” 
hydrogels as supports, which are removed after the 
spheroid fusion process.
2.2.3 Pick and Skewer
An ingenious solution to spheroids assembling problem 
has been developed in Japan [60]. Essentially, this is 
based on using a spheroids-assembling robot, which 
skewers them on a rectangular array of stainless steel 
micro-needles (“Kenzan)” [7]. Although technologically 
different, this method has common goals with regular 
bioprinting, such as the use of a nozzle to place the cells 
in a layer-by-layer formed 3D pattern, as well as the 
computer-assisted design and operation.
Recently, several pre-clinical examples of “Kenzan” 
scaffold-free biofabrication have been reported: 
Surgically-robust small diameter vascular grafts [61], 
tracheal [62] and urethral [63] tubes, neural bridges [64], 
beating cardiac patches [65], liver buds [66], and gastric 
diaphragm [63]. However, the Kenzan method is not without 
its own limitations, as we commented previously [7]. 
Among the more significant ones are: (i) Inability to 
import anatomically-correct 3D images; (ii) dependence 
of this method on the cells’ propensity to make spheroids 
of required size (commensurate with the inter-needle 
distance); (iii) secretion of a matrix strong enough to keep 
the construct compact; and (iv) length of the constructs 
limited to that of the microneedles.
3. Hybrid Biofabrication
Since the inception of bioprinting, those involved in 
its development rightly appreciated the difficulties 
derived from the use of a biomaterial and contemplated 
alternatives (for instance,[64]). These consist of using cell 
spheroids as building blocks for direct assembling the 3D 
construct, even if the spheroids themselves may require 
temporary support of some sort (such as “fugitive” 
hydrogels, or mechanical assistance).
Thus, some of the properties of scaffold-free 
biofabrication could be complemented, at least in part, by 
including biomaterials into the “scaffold-free” constructs. 
For example, these biomaterials could compensate 
for the slower intrinsic secretion of an ECM by some 
cell types, when prepared as spheroids. Alternatively, 
“classical” bioprinting may also benefit from several 
principles of the scaffold-free approach. Combined, 
this technological inter-breeding establishes the field of 
“hybrid” biofabrication.
The use of sacrificial hydrogels for holding spheroids in 
place, until fusion and during a “post-printing maturation” 
phase[54,65], is a typical example of hybrid bioprinting. 
Combination of spheroids with hydrogels could be 
profitable for regular bioprinting as well if instead of 
single-cell suspensions pre-formed spheroids are mixed 
within the bioink. In practice, this solution has been 
used to increase the human adipose-derived stromal cells 
survival and promoted their ability to differentiate after 
bioprinting [66]. The bioprinter can be also used to prepare 
cells mixed in bioinks of alginate [67] or collagen [68] in 
droplet form, as an efficient method of cell encapsulation, 
for subsequent in vitro or in vivo deployment. Moreover, 
the addition of fibrillary materials to hydrogels has been 
shown to improve their mechanical properties, thus 
generating stronger tissue-like constructs [30,69,70].
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Direct encapsulation of spheroids in polymeric 
cages [71], or incorporation of fibrillary matrix fragments 
into spheroids [72] are other examples of hybrid 
biofabrication, with the potential to improve spheroid-
based tissue engineering. For example, polycaprolactone 
was prepared as a fibrillary mesh by electrospinning, 
then fragmented by limited hydrolysis. The resulting 
material was added to mesenchymal stromal cells during 
centrifugation-assisted spheroid preparation, becoming 
uniformly distributed within their volume. Consequently, 
the resulting spheroids were less compact, and thus better 
aerated and nurtured, as compared to their scaffold-free 
counter-parts, which positively impacted on cell survival 
and osteogenic differentiation [72].
4. Post-printing Considerations
One of the big questions for all modes of biofabrication 
is what happens after the initial assembly of cells and 
spheroids, namely how will the cells captured in scaffolds 
survive, differentiate and proliferate? And how will 
spheroids hold together: Will there be sufficient intrinsic 
ECM produced to generate tissue-specific and tissue-
preserving connective tissue? In fact, the post-printing 
ECM formation and remodeling is one of the biggest 
current challenges in biofabrication. ECM components 
are made by quite a variety of cells, but the immobilization 
and their firm deposition around the cells is a challenge in 
standard aqueous culture conditions. One way to enhance 
ECM accumulation is the application of macromolecular 
crowding (MMC). Of relevance to this discussion is the 
use of polydisperse additives, some akin to “particulate” 
hydrogels, known MMC agents [73].
A special class of polymers with hydrogel-like properties, 
consisting of smaller molecular weight compounds 
than those commonly used for tissue engineering and 
bioprinting (e.g. Ficol 400), are increasingly used to bring 
the molecular concentration of the extracellular milieu to 
values close to those encountered in natural tissues [74]. 
These molecules produce the biophysical effect of MMC 
and are referred to simply as “crowders.” By size, charge, 
and hydration shell they exclude volume and collectively 
generate a fractional volume occupancy [75]. This has 
important consequences on the codissolved materials. The 
effects of MMC are mediated through an increase in the 
chance of direct interaction between the active molecules, 
thus accelerating the speed of their aggregation, or 
increasing their stability or the rate of their processing 
by codissolved enzymes. Collectively, these effects 
lead to a denser, more structured ECM, a phenomenon 
studied mostly in terms of  the properties of collagen I 
microfibrils[75-77], but also of other types of collagen, as well 
as laminin, fibronectin, etc. [78]. Addition of MMC to the 
medium used for spheroids preparation enhances matrix 
deposited and thus may facilitate their aggregation, shape, 
and stability [79]. This concept has been recently applied to 
bioprinting, as a means to manipulate the porosity within 
multilayered collagen-based hydrogels, by altering the 
collagen fibrillogenesis process through controlling the 
number of macromolecule-based bioink droplets printed 
on each collagen layer [80].
In summary, “hybrid biofabrication” is the cross-
pollination between approaches, methods, and materials 
already common in this field as elsewhere in technology, 
which could be further expanded and exploited as 
a proven method to programmatically increase the 
“vitality” (i.e., applicability and value generation) of the 
resulting products.
Following the basic structure of tissues which contain 
cells, extracellular matrix, and fluids, the composition of 
biofabricated tissue analogs may vary from biomaterials-
only, to cell suspensions, or cells-only constructs, 
with numerous intermediaries or “hybrid” situations 
(e.g., spheroids in hydrogels or fibers in spheroids as 
illustrated here). Correspondingly, these constructs can be 
used in a spectrum of applications ranging from inorganic 
biocompatible prostheses to live cell-based implants. 
Macromolecular crowding agents can be also added to 
cell preparations to bring their environment closer to the 
natural density. The methods of bioprinting may also 
come in these two versions, namely biomaterial-based or 
cell-based (“scaffold-free).”
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